BRT Biotechnologies, Inc. — Form D/A
BRT Biotechnologies, Inc. of CLAREMONT, CA, a company, filed a Form D amendment with the SEC on 2023-10-26. The offering totals $300K, of which $273K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-26
- Form: D/A
- Accession: 0001994719-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $273K
- Remaining: $28K
- Investors: 7
- Date of first sale: 2023-09-20
- Revenue range: Decline to Disclose
- SEC file number: 021-493917
Issuer
- Name: BRT Biotechnologies, Inc.
- CIK: 0001994719
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: SEAVER NORTH 645 N COLLEGE AVE, CLAREMONT, CA, 91711
- Phone: 909-447-9472
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Gregory Copeland | Director | Claremont, CA |
| Jane Liu | Director | Claremont, CA |
| Gregory Copeland | Executive Officer | Claremont, CA |
| Jane Liu | Executive Officer | Claremont, CA |
| Gregory Copeland | Related Person | Claremont, CA |
| Jane Liu | Related Person | Claremont, CA |
Other filings by this issuer (2)
More